Main Navigation
 
Search
Advanced Search>>
Free Newsletter
Subscribe
Unsubscribe
 
 
  
Health Headlines

Get the latest news in prevention and health matters. This feature includes daily postings and recent archives to keep you up to date on health reports and wires around the world.
Weekly Wellness
Get informed with weekly wellness facts in a diversity of health topics from prevention to fitness and nutrition.
Tips
Great tips on what you need to know about keeping healthy and active all year round.

 

Dangeous Supplements Causing Deaths

WASHINGTON (Reuters Health) - US government researchers reported more evidence Thursday that an industrial solvent sold over the Internet as a dietary supplement is causing the same dangerous symptoms as seen with the so-called ``date rape'' drug, gamma-hydroxybutyrate (GHB).

It is not surprising, since the solvent, called 1,4 butanediol (BD), is metabolized into GHB in the body, the researchers said.

BD and related chemicals are commonly sold as sleep aids, weight reducers and muscle promoters and even as ``organic'' cleaning products. BD ingestion causes extreme euphoria and sedation, but can lead to severe respiratory depression and coma. Despite warnings issued by the Food and Drug Administration (FDA), they still seem to be in widespread use.

From January 1999 to August 2000, the FDA division that oversees dietary supplements received 48 reports of acute BD intoxication, including loss of consciousness, dangerously low respiratory rates, vomiting and slowed heartbeat. There were six deaths, and six patients had severe withdrawal because of their addiction.

The reports were described at the FDA's annual Science Forum in Washington.

BD is often the main ingredient of supplements claiming to enhance sexual function, build muscle mass, or bring on sleep. Product names include Zen, NRG-3, Soma Solutions, Enliven and Serenity, and the BD is often listed as ``tetramethylene glycol'' or ``Sucol B,'' according to the FDA researchers.

Back in 1999, the FDA designated BD as a Class I health hazard, citing it as ``a potentially life-threatening risk.'' Officials noted then that BD may increase the effects of alcohol and is even more dangerous if consumed with other depressant drugs.

In April 2000, the Drug Enforcement Administration (DEA) made BD a scheduled substance. GHB, and a precursor, gamma-butyrolactone (GBL), had already both been scheduled by the DEA in January 1999.

Since the FDA started warning consumers of the potential dangers of BD, GHB and GBL more than a year ago, many of the products formerly sold as dietary supplements have changed their names or the intended use of the product, such as calling it a ``cleaning solution.''

Yet information provided about the product retains many of the former claims, such as ``improves sexual desire and function,'' Drs. Deborah L. Zvosec and Stephen W. Smith of the Hennepin County Medical Center in Minneapolis, Minnesota, told Reuters Health in January.

The researchers published a review of nine cases of BD abuse published in The New England Journal of Medicine in January.

The Drug Enforcement Administration is continuing to crack down on sales of BD, which should decrease the legal supply, the FDA researchers said. But, the decreased supply could lead to more addicts going through withdrawal, they added.

Reference Source 89

For more information on how to prevent obesity or diabetes, use
PreventDisease.com's "Quick Prevention Resources".

Select a Channel